Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
5.27
+0.05 (0.96%)
May 28, 2026, 11:41 AM EDT - Market open
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.11 billion as of May 28, 2026. Its market cap has increased by 149.43% in one year.
Market Cap
1.11B
Enterprise Value
1.26B
1-Year Change
149.43%
Ranking
Category
Stock Price
$5.27
Market Cap Chart
Since October 26, 2018, Inventiva's market cap has increased from $151.00M to $1.11B, an increase of 632.01%. That is a compound annual growth rate of 30.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.10B | 24.09% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 1.22B |
| Zenas BioPharma | 1.14B |
| Maravai LifeSciences Holdings | 1.13B |
| Olema Pharmaceuticals | 1.13B |
| DBV Technologies | 1.11B |
| Avalyn Pharma | 1.11B |
| Aktis Oncology | 1.10B |
| EyePoint | 1.10B |